Abstract

The CYP27B1 gene encodes 25-hydroxyvitamin D-1α-hydroxylase. Mutations of this gene cause vitamin D-dependent rickets type 1A (VDDR-IA, OMIM 264700), which is a rare autosomal recessive disorder. To investigate CYP27B1 mutations, we studied 8 patients from 7 unrelated families. All coding exons and intron-exon boundaries of CYP27B1 gene were amplified by PCR from peripheral leukocyte DNA and subsequently sequenced. Homozygous mutations in the CYP27B1 gene were found in all the patients and heterozygous mutations were present in their normal parents. One novel single nucleotide variation (SNV, c.1215 T>C, p.R379R in the last nucleotide of exon 7) and three novel mutations were identified:, a splice donor site mutation (c.1215+2T>A) in intron 7, a 16-bp deletion in exon 6 (c.1022-1037del16), and a 2-bp deletion in exon 5 (c.934_935delAC). Both c.1215 T>C and c.1215+2T>A were present together in homozygous form in two unrelated patients, and caused exon 7 skipping. However, c.1215 T>C alone has no effect on pre-mRNA splicing. The skipping of exon 7 resulted in a shift of downstream reading frame and a premature stop codon 57 amino acids from L380 (p.L380Afs*57). The intra-exon deletions of c.1022-1037del16 and c.934_935delAC also resulted in a frameshift and the creation of premature stop codons at p.T341Rfs*5, and p.T312Rfs*19, respectively, leading to the functional inactivation of the CYP27B1 gene. Clinically, all the patients required continued calcitriol treatment and the clinical presentations were consistent with the complete loss of vitamin D1α-hydroxylase activity. In conclusion, three novel mutations have been identified. All of them caused frameshift and truncated proteins. The silent c.1215 T>C SNV has no effect on pre-mRNA splicing and it is likely a novel SNP. The current study further expands the CYP27B1 mutation spectrum.

Highlights

  • Vitamin D is a group of biologically inactive, fat-soluble pro-hormones

  • Patients II-3 and IV-3 presented with severe hypophosphatemia associated with normal serum calcium, which is consistent with stage II rickets (Table 1)

  • To identify the underlying genetic defects leading to 25-hydroxyvitamin D-1α-hydroxylase deficiency, we sequenced the entire coding region and intron-exon boundaries of the CYP27B1 gene in the patients and their parents

Read more

Summary

Introduction

Vitamin D (calciferols) is a group of biologically inactive, fat-soluble pro-hormones. Vitamin D2 is derived from plants and vitamin D3 is produced by animal tissues or from the conversion of 7-dehydrocholesterol in the human skin by the solar Ultraviolet B (UVB) radiation at the wavelength of 280–315 nm [1]. Both forms of vitamin D need two-step hydroxylation to become biologically active. The first step occurs in the liver where vitamin D is hydroxylated to 25-hydroxyvitamin D (25OHD) by several hepatic enzymes having 25-hydroxylase activity, such as microsomal CYP2R1[2] and CYP3A4 [3], and mitochondrial CYP27A1[4]. The renal synthesis of 1,25-(OH)2D from its precursor, 25(OH)D is a rate-limiting step and is tightly regulated by serum1,25-(OH)2D, parathyroid hormone (PTH), FGF23, calcium, and phosphate, with renal 1α-hydroxylase being stimulated by PTH, hypophosphatemia, or hypocalcaemia, and inhibited by FGF23 [1, 14, 15]

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.